It can detect the presence of abnormal hemoglobin in a small blood sample within a few minutes
Mylab Discovery Solutions has launched a strip-based, rapid point of care test, PathoCatch Sickle Cell rapid test for Sickle Cell Anemia. Approved by CDSCO, this test aims to transform the way healthcare professionals diagnose and manage SCA, offering rapid and accurate results at the patient’s site. This will be instrumental in supporting the Govt.’s mission to eliminate SCA by 2047 from India.
It can detect the presence of abnormal hemoglobin in a small blood sample within a few minutes. It can be used easily by healthcare professionals without the use of laboratory equipment. The test is made up of three indicators, which detect the presence of hemoglobin A, S and C, allowing the user to rapidly distinguish between normal, carrier and sickle cell samples. It has a both combined sensitivity and specificity of 100 per cent, making it one of the fastest and most accurate tests in India.
Speaking about the launch of the test, Hasmukh Rawal, MD & Co-founder, Mylab said, ” The public health implications of sickle-cell anaemia are significant as people who have sickle cell anemia face potentially life-threatening medical complications. Timely diagnostic testing and comprehensive care can significantly reduce morbidity and mortality from the disease. We are confident that PathoCatch Sickle Cell rapid test will help reduce the burden of sickle cell anemia in our country and support the government’s mission to eliminate the diseases by 2047.”
PathoCatch Sickle Cell rapid test can be used in blood banks, gynecology hospitals, primary/secondary health centers and government screening programs. The test can be used in resource-limited regions with a high prevalence of SCA, to provide timely diagnosis and support SCA screening programs. The test kit will be available at hospitals and labs by the end of this month.